Vermillion EPS - Earnings per Share 2006-2019 | VRML

Vermillion eps - earnings per share from 2006 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Vermillion Annual EPS
2018 $-0.16
2017 $-0.20
2016 $-0.29
2015 $-0.41
2014 $-0.53
2013 $-0.42
2012 $-0.48
2011 $-1.25
2010 $-1.83
2009 $-3.31
2008 $-2.87
2007 $0.00
2006 $0.00
2005 $0.00
Vermillion Quarterly EPS
Q1 2019 $-0.05
Q4 2018 $-0.03
Q3 2018 $-0.04
Q2 2018 $-0.04
Q1 2018 $-0.05
Q4 2017 $-0.05
Q3 2017 $-0.06
Q2 2017 $-0.04
Q1 2017 $-0.05
Q4 2016 $-0.06
Q3 2016 $-0.07
Q2 2016 $-0.07
Q1 2016 $-0.09
Q4 2015 $-0.10
Q3 2015 $-0.10
Q2 2015 $-0.11
Q1 2015 $-0.10
Q4 2014 $-0.11
Q3 2014 $-0.16
Q2 2014 $-0.15
Q1 2014 $-0.11
Q4 2013 $-0.04
Q3 2013 $-0.10
Q2 2013 $-0.11
Q1 2013 $-0.17
Q4 2012 $-0.10
Q3 2012 $-0.13
Q2 2012 $-0.13
Q1 2012 $-0.12
Q4 2011 $-0.21
Q3 2011 $-0.31
Q2 2011 $-0.39
Q1 2011 $-0.34
Q4 2010 $-0.38
Q3 2010 $-0.26
Q2 2010 $-0.07
Q1 2010 $-1.14
Q4 2009 $-0.86
Q3 2009 $-1.72
Q2 2009 $-0.28
Q1 2009 $-0.44
Q4 2008 $0.00
Q3 2008 $0.00
Q2 2008 $0.00
Q1 2008 $0.00
Q4 2007 $0.00
Q3 2007 $0.00
Q2 2007 $0.00
Q1 2007 $0.00
Q4 2006 $0.00
Q3 2006 $0.00
Q2 2006 $0.00
Q1 2006 $0.00
Q4 2005 $0.00
Q3 2005 $0.00
Q2 2005 $0.00
Q1 2005 $0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.053B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $111.400B 23.74
Intuitive Surgical (ISRG) United States $57.658B 50.43
Edwards Lifesciences (EW) United States $45.061B 43.86
IDEXX Laboratories (IDXX) United States $24.095B 60.45
Fresenius Medical Care AG KGaA (FMS) Germany $20.454B 13.55
Teleflex (TFX) United States $16.929B 35.93
Olympus (OCPNY) Japan $16.011B 119.79
DexCom (DXCM) United States $15.900B 235.63
SONOVA HOLDING (SONVY) Switzerland $15.039B 0.00
Hologic (HOLX) United States $13.325B 21.03
STERIS (STE) Ireland $12.804B 29.53
Sysmex ADR (SSMXY) Japan $12.774B 34.44
Varian Medical Systems (VAR) United States $9.856B 23.58
ABIOMED (ABMD) United States $8.868B 50.76
Masimo (MASI) United States $8.021B 48.67
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.262B 23.48
Globus Medical (GMED) United States $5.084B 32.26
Penumbra (PEN) United States $5.042B 181.15
Elekta AB (EKTAY) Sweden $4.829B 38.53
Tandem Diabetes Care (TNDM) United States $3.964B 0.00
LivaNova (LIVN) United Kingdom $3.828B 29.19
Cantel Medical (CMD) United States $3.708B 37.61
Wright Medical Group (WMGI) Netherlands $2.796B 245.22
Nevro (NVRO) United States $2.630B 0.00
Integer Holdings (ITGR) United States $2.487B 17.60
Nihon Kohden (NHNKY) Japan $2.463B 24.79
Glaukos (GKOS) United States $2.226B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.636B 30.34
Silk Road Medical (SILK) United States $1.284B 0.00
Veracyte (VCYT) United States $1.226B 0.00
OPKO Health (OPK) United States $1.200B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $1.022B 32.08
Natus Medical (NTUS) United States $1.016B 23.67
CryoLife (CRY) United States $0.996B 94.86
Accelerate Diagnostics (AXDX) United States $0.988B 0.00
Inogen (INGN) United States $0.981B 24.04
Tactile Systems Technology (TCMD) United States $0.948B 117.14
Luminex (LMNX) United States $0.917B 0.00
Pacific Biosciences Of California (PACB) United States $0.873B 0.00
Mesa Laboratories (MLAB) United States $0.846B 39.07
AngioDynamics (ANGO) United States $0.696B 22.78
AxoGen (AXGN) United States $0.656B 0.00
Quotient (QTNT) Switzerland $0.638B 0.00
Intersect ENT (XENT) United States $0.496B 0.00
Si-Bone (SIBN) United States $0.485B 0.00
OrthoPediatrics (KIDS) United States $0.481B 0.00
ViewRay (VRAY) United States $0.420B 0.00
Fluidigm (FLDM) United States $0.403B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.370B 14.21
GenMark Diagnostics (GNMK) United States $0.365B 0.00
Alphatec Holdings (ATEC) United States $0.354B 0.00
Sientra (SIEN) United States $0.345B 0.00
Semler Scientific (SMLR) United States $0.297B 50.21
Accuray (ARAY) United States $0.241B 0.00
RTI Surgical (RTIX) United States $0.237B 35.67
IRadimed (IRMD) United States $0.227B 37.70
SeaSpine Holdings (SPNE) United States $0.210B 0.00
Stereotaxis (STXS) United States $0.184B 0.00
Neuronetics (STIM) United States $0.181B 0.00
ConforMIS (CFMS) United States $0.139B 0.00
Sensus Healthcare (SRTS) United States $0.107B 0.00
Second Sight Medical Products (EYES) United States $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.093B 0.00
Apollo Endosurgery (APEN) United States $0.073B 0.00
Spectral Diagnostics (EDTXF) Canada $0.064B 0.00
Ekso Bionics Holdings (EKSO) United States $0.061B 0.00
T2 Biosystems (TTOO) United States $0.051B 0.00
Helius Medical Technologies (HSDT) United States $0.048B 0.00
Bioanalytical Systems (BASI) United States $0.029B 0.00
Restoration Robotics (HAIR) United States $0.028B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.027B 0.00
Ra Medical Systems (RMED) United States $0.026B 0.00
Nuvectra (NVTR) United States $0.024B 0.00
ReWalk Robotics (RWLK) Israel $0.023B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
DarioHealth (DRIO) Israel $0.017B 0.00
Lianluo Smart (LLIT) China $0.015B 0.00
OBALON THERPTCS (OBLN) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Avinger (AVGR) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00